Evonik Evonik

X

Find Radio Compass News for Ziprasidone

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • CAPSULE;ORAL - EQ 20MG BASE
  • CAPSULE;ORAL - EQ 40MG BASE
  • CAPSULE;ORAL - EQ 60MG BASE
  • CAPSULE;ORAL - EQ 80MG BASE

https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-june-28-2023-96236.pdf

FDA
28 Jun 2023

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and

FDA
14 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208988

FDA
25 Aug 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204117

FDA
27 Dec 2016

https://www.reuters.com/article/pfizer-fda-antipsychotic/fda-warns-pfizers-antipsychotic-could-cause-fatal-skin-reaction-idUSL3N0TV4MH20141211

REUTERS
16 Dec 2014

http://pharmaceuticals.einnews.com/pr_news/239287157/ziprasidone-marketed-as-geodon-and-generics-drug-safety-communication-rare-but-potentially-fatal-skin-reactions

Press Release EIN Newsdesk
11 Dec 2014
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY